Your browser doesn't support javascript.
loading
Immunogenicity and safety of Mebella™ vaccine developed by Human Biologicals Institute in a Phase II/III, randomized, multicentric, non-inferiority study.
Krishna Susarla, Sai; Jahagirdar, Rahul; Ghosh Uttam, Kheya; Srikanth Bhatt, S; Prashanth, S; Rajapantula, Vasudev; Satish, M; Rajashakar, B C; Sandhya, G; Rajendra, L; Prasad Sahoo, Devi; Kumar Kanakasapapathy, Anand.
Afiliação
  • Krishna Susarla S; Human Biologicals Institute (A Division of Indian Immunologicals Limited), Hyderabad, Telangana, India. Electronic address: s.saikrishna@indimmune.com.
  • Jahagirdar R; Department of Pediatrics, Bharati Vidyapeeth (Deemed to be University) Medical College & Hospital, Pune, Maharashtra, India.
  • Ghosh Uttam K; Department of Pediatric Medicine, Institute of Child Health, Kolkata, West Bengal, India.
  • Srikanth Bhatt S; Department of Pediatrics, Gandhi Medical College and Hospital, Secunderabad, Telangana, India.
  • Prashanth S; Department of Pediatrics, Cheluvamba Hospital, Mysore Medical College and Research Institute, Mysore, Karnataka, India.
  • Rajapantula V; Department of Medicine, King George Hospital, Visakhapatnam, Andhra Pradesh, India.
  • Satish M; Human Biologicals Institute (A Division of Indian Immunologicals Limited), Hyderabad, Telangana, India.
  • Rajashakar BC; Human Biologicals Institute (A Division of Indian Immunologicals Limited), Hyderabad, Telangana, India.
  • Sandhya G; Human Biologicals Institute (A Division of Indian Immunologicals Limited), Hyderabad, Telangana, India.
  • Rajendra L; Human Biologicals Institute (A Division of Indian Immunologicals Limited), Hyderabad, Telangana, India.
  • Prasad Sahoo D; Human Biologicals Institute (A Division of Indian Immunologicals Limited), Hyderabad, Telangana, India.
  • Kumar Kanakasapapathy A; Human Biologicals Institute (A Division of Indian Immunologicals Limited), Hyderabad, Telangana, India.
Vaccine ; 41(44): 6558-6564, 2023 Oct 20.
Article em En | MEDLINE | ID: mdl-37659893

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article